Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 1/2015

01-01-2015 | Original Article

Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?

Authors: F. B. van Hoeij, R. G. M. Keijsers, B. C. A. J. Loffeld, G. Dun, P. H. G. M. Stadhouders, B. L. A. M. Weusten

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2015

Login to get access

Abstract

Purpose

In patients undergoing 18F-FDG PET/CT, incidental colonic focal lesions can be indicative of inflammatory, premalignant or malignant lesions. The maximum standardized uptake value (SUVmax) of these lesions, representing the FDG uptake intensity, might be helpful in differentiating malignant from benign lesions, and thereby be helpful in determining the urgency of colonoscopy. The aim of our study was to assess the incidence and underlying pathology of incidental PET-positive colonic lesions in a large cohort of patients, and to determine the usefulness of the SUVmax in differentiating benign from malignant pathology.

Methods

The electronic records of all patients who underwent FDG PET/CT from January 2010 to March 2013 in our hospital were retrospectively reviewed. The main indications for PET/CT were: characterization of an indeterminate mass on radiological imaging, suspicion or staging of malignancy, and suspicion of inflammation. In patients with incidental focal FDG uptake in the large bowel, data regarding subsequent colonoscopy were retrieved, if performed within 120 days. The final diagnosis was defined using colonoscopy findings, combined with additional histopathological assessment of the lesion, if applicable.

Results

Of 7,318 patients analysed, 359 (5 %) had 404 foci of unexpected colonic FDG uptake. In 242 of these 404 lesions (60 %), colonoscopy follow-up data were available. Final diagnoses were: adenocarcinoma in 25 (10 %), adenoma in 90 (37 %), and benign in 127 (53 %). The median [IQR] SUVmax was significantly higher in adenocarcinoma (16.6 [12 – 20.8]) than in benign lesions (8.2 [5.9 – 10.1]; p < 0.0001), non-advanced adenoma (8.3 [6.1 – 10.5]; p < 0.0001) and advanced adenoma (9.7 [7.2 – 12.6]; p < 0.001). The receiver operating characteristic curve of SUVmax for malignant versus nonmalignant lesions had an area under the curve of 0.868 (SD ± 0.038), the optimal cut-off value being 11.4 (sensitivity 80 %, specificity 82 %, positive predictive value 34 %, negative predictive value 98 %).

Conclusion

In these patients with incidental colonic focal activity undergoing PET/CT (the largest series published to date), malignancies had significantly higher SUVmax values than all other types of lesions. However, SUVmax could not distinguish between benign lesions and adenomas. In conclusion, all incidental findings in the colon should be further evaluated and lesions with SUVmax ≥11.4 should be evaluated without delay.
Literature
1.
go back to reference Scheibler F, Zumbé P, Janssen I, Viebahn M, Schröer-Günther M, Grosselfinger R, et al. Randomized controlled trials on PET: a systematic review of topics, design, and quality. J Nucl Med. 2012;53(7):1016–25.PubMedCrossRef Scheibler F, Zumbé P, Janssen I, Viebahn M, Schröer-Günther M, Grosselfinger R, et al. Randomized controlled trials on PET: a systematic review of topics, design, and quality. J Nucl Med. 2012;53(7):1016–25.PubMedCrossRef
2.
go back to reference Krause BJ, Schwarzenböck S, Souvatzoglou M. FDG PET and PET-CT. Recent results. Cancer Res. 2013;187:351–69. Krause BJ, Schwarzenböck S, Souvatzoglou M. FDG PET and PET-CT. Recent results. Cancer Res. 2013;187:351–69.
3.
4.
go back to reference Treglia F, Taralli S, Giordano A. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28(2):87–94.PubMed Treglia F, Taralli S, Giordano A. Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review. Sarcoidosis Vasc Diffuse Lung Dis. 2011;28(2):87–94.PubMed
5.
go back to reference Cavalcanti Filho JL, de Souza Leão Lima R, de Souza Machado Neto L, Kayat Bittencourt L, Domingues RC, da Fonseca LM. PET-CT and vascular disease: current concepts. Eur J Radiol. 2011;80(1):60–7.PubMedCrossRef Cavalcanti Filho JL, de Souza Leão Lima R, de Souza Machado Neto L, Kayat Bittencourt L, Domingues RC, da Fonseca LM. PET-CT and vascular disease: current concepts. Eur J Radiol. 2011;80(1):60–7.PubMedCrossRef
6.
go back to reference Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET-CT. AJR Am J Roentgenol. 2005;185:495–500.PubMedCrossRef Gutman F, Alberini JL, Wartski M, Vilain D, Le Stanc E, Sarandi F, et al. Incidental colonic focal lesions detected by FDG PET-CT. AJR Am J Roentgenol. 2005;185:495–500.PubMedCrossRef
7.
go back to reference Zhuang H, Hickeson M, Chacko TK, Duarte PS, Nakhoda KZ, Feng Q, et al. Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med. 2002;27:628–32.PubMedCrossRef Zhuang H, Hickeson M, Chacko TK, Duarte PS, Nakhoda KZ, Feng Q, et al. Incidental detection of colon cancer by FDG positron emission tomography in patients examined for pulmonary nodules. Clin Nucl Med. 2002;27:628–32.PubMedCrossRef
8.
go back to reference Putora PM, Müller J, Borovicka J, Plasswilm L, Schmidt F. Relevance of incidental colorectal FDG-PET-CT-enhanced lesions. Onkologie. 2013;36:200–4.PubMedCrossRef Putora PM, Müller J, Borovicka J, Plasswilm L, Schmidt F. Relevance of incidental colorectal FDG-PET-CT-enhanced lesions. Onkologie. 2013;36:200–4.PubMedCrossRef
9.
go back to reference Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging. 1999;2:273–80.PubMedCrossRef Kim S, Chung JK, Kim BT, Kim SJ, Jeong JM, Lee DS, et al. Relationship between gastrointestinal F-18-fluorodeoxyglucose accumulation and gastrointestinal symptoms in whole-body PET. Clin Positron Imaging. 1999;2:273–80.PubMedCrossRef
10.
go back to reference Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study. Colorectal Dis. 2011;13(11):e374–8.PubMedCrossRef Peng J, He Y, Xu J, Sheng J, Cai S, Zhang Z. Detection of incidental colorectal tumours with 18F-labelled 2-fluoro-2-deoxyglucose positron emission tomography/computed tomography scans: results of a prospective study. Colorectal Dis. 2011;13(11):e374–8.PubMedCrossRef
11.
go back to reference Farquharson AL, Chopra A, Ford A, Matthews S, Amin SN, De Noronha R. Incidental focal colonic lesions found on 18Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management. Colorectal Dis. 2011;14:e56–61.CrossRef Farquharson AL, Chopra A, Ford A, Matthews S, Amin SN, De Noronha R. Incidental focal colonic lesions found on 18Fluorodeoxyglucose positron emission tomography/computed tomography scan: further support for a national guideline on definitive management. Colorectal Dis. 2011;14:e56–61.CrossRef
12.
go back to reference Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics. 2007;27:145–59.PubMedCrossRef Prabhakar HB, Sahani DV, Fischman AJ, Mueller PR, Blake MA. Bowel hot spots at PET-CT. Radiographics. 2007;27:145–59.PubMedCrossRef
13.
go back to reference Zasadny K, Wahl R. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847–50.PubMedCrossRef Zasadny K, Wahl R. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology. 1993;189:847–50.PubMedCrossRef
14.
go back to reference Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308–14.PubMedCrossRef Cook GJR, Fogelman I, Maisey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308–14.PubMedCrossRef
15.
go back to reference Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004;24:1411–31.PubMedCrossRef Kostakoglu L, Hardoff R, Mirtcheva R, Goldsmith SJ. PET-CT fusion imaging in differentiating physiologic from pathologic FDG uptake. Radiographics. 2004;24:1411–31.PubMedCrossRef
16.
go back to reference Vansteenkiste JF, Stroobants SG. The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J. 2001;17:802–20.PubMedCrossRef Vansteenkiste JF, Stroobants SG. The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J. 2001;17:802–20.PubMedCrossRef
17.
go back to reference Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783–7.PubMedCrossRef Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783–7.PubMedCrossRef
18.
go back to reference Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001;28:1766–9.PubMedCrossRef Drenth JP, Nagengast FM, Oyen WJ. Evaluation of (pre-)malignant colonic abnormalities: endoscopic validation of FDG-PET findings. Eur J Nucl Med. 2001;28:1766–9.PubMedCrossRef
19.
go back to reference Kei PL, Vikram R, Yeung HW, Stroehlein JR, Macapinlac HA. Incidental finding of focal FDG uptake in the bowel during PET-CT: CT features and correlation with histopathologic results. AJR Am J Roentgenol. 2010;194(5):W401–6.PubMedCrossRef Kei PL, Vikram R, Yeung HW, Stroehlein JR, Macapinlac HA. Incidental finding of focal FDG uptake in the bowel during PET-CT: CT features and correlation with histopathologic results. AJR Am J Roentgenol. 2010;194(5):W401–6.PubMedCrossRef
20.
go back to reference Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET-CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46(5):758–62.PubMed Israel O, Yefremov N, Bar-Shalom R, Kagana O, Frenkel A, Keidar Z, et al. PET-CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46(5):758–62.PubMed
21.
go back to reference Chen YK, Kao CH, Liao AC, Shen YY, Su CT. Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan. Anticancer Res. 2003;23(5b):4357–61.PubMed Chen YK, Kao CH, Liao AC, Shen YY, Su CT. Colorectal cancer screening in asymptomatic adults: the role of FDG PET scan. Anticancer Res. 2003;23(5b):4357–61.PubMed
22.
go back to reference Luboldt W, Volker T, Wiedemann B, Zöphel K, Wehrmann U, Koch A, et al. Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off. Eur Radiol. 2010;20(9):2274–85.PubMedCentralPubMedCrossRef Luboldt W, Volker T, Wiedemann B, Zöphel K, Wehrmann U, Koch A, et al. Detection of relevant colonic neoplasms with PET/CT: promising accuracy with minimal CT dose and a standardised PET cut-off. Eur Radiol. 2010;20(9):2274–85.PubMedCentralPubMedCrossRef
23.
go back to reference Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181–200.PubMedCentralPubMedCrossRef Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, et al. FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. Eur J Nucl Med Mol Imaging. 2010;37(1):181–200.PubMedCentralPubMedCrossRef
24.
go back to reference Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–58.PubMedCrossRef Jamar F, Buscombe J, Chiti A, Christian PE, Delbeke D, Donohoe KJ, et al. EANM/SNMMI guideline for 18F-FDG use in inflammation and infection. J Nucl Med. 2013;54(4):647–58.PubMedCrossRef
25.
go back to reference Treglia G, Calcagni ML, Rufini V, Leccisotti L, Meduri GM, Spitilli MG, et al. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. Colorectal Dis. 2012;14(2):174–80.PubMedCrossRef Treglia G, Calcagni ML, Rufini V, Leccisotti L, Meduri GM, Spitilli MG, et al. Clinical significance of incidental focal colorectal (18)F-fluorodeoxyglucose uptake: our experience and a review of the literature. Colorectal Dis. 2012;14(2):174–80.PubMedCrossRef
26.
go back to reference Kamel EM, Thumshirn M, Truninger K, Schiesser M, Fried M, Padberg B, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET-CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45(11):1804–10.PubMed Kamel EM, Thumshirn M, Truninger K, Schiesser M, Fried M, Padberg B, et al. Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET-CT: correlation with endoscopic and histopathologic results. J Nucl Med. 2004;45(11):1804–10.PubMed
Metadata
Title
Incidental colonic focal FDG uptake on PET/CT: can the maximum standardized uptake value (SUVmax) guide us in the timing of colonoscopy?
Authors
F. B. van Hoeij
R. G. M. Keijsers
B. C. A. J. Loffeld
G. Dun
P. H. G. M. Stadhouders
B. L. A. M. Weusten
Publication date
01-01-2015
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2015
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-014-2887-3

Other articles of this Issue 1/2015

European Journal of Nuclear Medicine and Molecular Imaging 1/2015 Go to the issue